iifl-logo-icon 1

Welcure Drugs & Pharmaceuticals Ltd AGM

6.99
(4.95%)
Jul 22, 2024|03:40:00 PM

Welcure Drugs CORPORATE ACTIONS

23/07/2023calendar-icon
22/07/2024calendar-icon
PurposeAGM DateAnnouncement Date
AGM28 Sep 20234 Sep 2023
the outcome of the Board Meeting held today i.e. on Monday, 04 Sept, 2023 at 04.30 P.M and concluded at 6.00 P.M at the registered office of the Company.1.The Board considered and approved Financial Statement, Notice of 31st AGM and Directors Report of the Company 2.The Board appointed Mr. Vivek Kumar as the Scrutinizer for the purpose of 31st Annual General Meeting.3.The Board appointed Mr. Manish Guptaas Internal Auditor of the company for the financial year 2023-24.4. The Board considered the Resignation of M/s V. P. Gupta & Co. from the post of Statutory Auditor etc Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. We hereby submit the proceedings of 31st AGM of the Company. which was held today i.e, Thursday, 28th September, 2023 at 12:30 P.M. through Video Conferencing or other audio video means. (As Per BSE Announcement dated on 28.09.2023) The 31st AGM of the Company was held on Thursday, 28th September, 2023 at 12:30 P.M through Video Conferencing mode. We are hereby submitting the copy of Scrutinizers Report. (As per BSE Announcement Dated on 30/09/2023)

Welcure Drugs: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.